Global Biosimilars/Follow-on-Biologics Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Biosimilars/Follow-on-Biologics will have significant change from previous year. According to our (LP Information) latest study, the global Biosimilars/Follow-on-Biologics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biosimilars/Follow-on-Biologics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Biosimilars/Follow-on-Biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilars/Follow-on-Biologics market, reaching US$ million by the year 2028. As for the Europe Biosimilars/Follow-on-Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biosimilars/Follow-on-Biologics players cover Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, and LG Life Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Biosimilars/Follow-on-Biologics will have significant change from previous year. According to our (LP Information) latest study, the global Biosimilars/Follow-on-Biologics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Biosimilars/Follow-on-Biologics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Biosimilars/Follow-on-Biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilars/Follow-on-Biologics market, reaching US$ million by the year 2028. As for the Europe Biosimilars/Follow-on-Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biosimilars/Follow-on-Biologics players cover Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, and LG Life Sciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
- Peptide
- Others
- Blood Disorders
- Oncology Diseases
- Chronic and Autoimmune Diseases
- Growth Hormone Deficiencies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries
- LG Life Sciences
- Celltrion
- Biocon
- Hospira
- Merck Group
- Biogen idec, Inc.
- Genentech (Roche Group)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Country/Region, 2017, 2022 & 2028
2.2 Biosimilars/Follow-on-Biologics Segment by Type
2.2.1 Human Growth Hormone
2.2.2 Erythropoietin
2.2.3 Monoclonal Antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.2.7 Peptide
2.2.8 Others
2.3 Biosimilars/Follow-on-Biologics Sales by Type
2.3.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
2.3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022)
2.4 Biosimilars/Follow-on-Biologics Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.4.3 Chronic and Autoimmune Diseases
2.4.4 Growth Hormone Deficiencies
2.4.5 Others
2.5 Biosimilars/Follow-on-Biologics Sales by Application
2.5.1 Global Biosimilars/Follow-on-Biologics Sale Market Share by Application (2017-2022)
2.5.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022)
3 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY COMPANY
3.1 Global Biosimilars/Follow-on-Biologics Breakdown Data by Company
3.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Company (2020-2022)
3.1.2 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)
3.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Company (2020-2022)
3.2.1 Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022)
3.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)
3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Company
3.4 Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilars/Follow-on-Biologics Product Location Distribution
3.4.2 Players Biosimilars/Follow-on-Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Biosimilars/Follow-on-Biologics Market Size by Geographic Region (2017-2022)
4.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Geographic Region
4.2 World Historic Biosimilars/Follow-on-Biologics Market Size by Country/Region (2017-2022)
4.2.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Country/Region
4.3 Americas Biosimilars/Follow-on-Biologics Sales Growth
4.4 APAC Biosimilars/Follow-on-Biologics Sales Growth
4.5 Europe Biosimilars/Follow-on-Biologics Sales Growth
4.6 Middle East & Africa Biosimilars/Follow-on-Biologics Sales Growth
5 AMERICAS
5.1 Americas Biosimilars/Follow-on-Biologics Sales by Country
5.1.1 Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
5.1.2 Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
5.2 Americas Biosimilars/Follow-on-Biologics Sales by Type
5.3 Americas Biosimilars/Follow-on-Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars/Follow-on-Biologics Sales by Region
6.1.1 APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022)
6.1.2 APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022)
6.2 APAC Biosimilars/Follow-on-Biologics Sales by Type
6.3 APAC Biosimilars/Follow-on-Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilars/Follow-on-Biologics by Country
7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
7.2 Europe Biosimilars/Follow-on-Biologics Sales by Type
7.3 Europe Biosimilars/Follow-on-Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars/Follow-on-Biologics by Country
8.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
8.2 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type
8.3 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics
10.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
10.4 Industry Chain Structure of Biosimilars/Follow-on-Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilars/Follow-on-Biologics Distributors
11.3 Biosimilars/Follow-on-Biologics Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Region
12.1.1 Global Biosimilars/Follow-on-Biologics Forecast by Region (2023-2028)
12.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilars/Follow-on-Biologics Forecast by Type
12.7 Global Biosimilars/Follow-on-Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Biosimilars/Follow-on-Biologics Product Offered
13.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Synthon Pharmaceuticals
13.2.1 Synthon Pharmaceuticals Company Information
13.2.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered
13.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Synthon Pharmaceuticals Main Business Overview
13.2.5 Synthon Pharmaceuticals Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered
13.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 LG Life Sciences
13.4.1 LG Life Sciences Company Information
13.4.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered
13.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 LG Life Sciences Main Business Overview
13.4.5 LG Life Sciences Latest Developments
13.5 Celltrion
13.5.1 Celltrion Company Information
13.5.2 Celltrion Biosimilars/Follow-on-Biologics Product Offered
13.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Celltrion Main Business Overview
13.5.5 Celltrion Latest Developments
13.6 Biocon
13.6.1 Biocon Company Information
13.6.2 Biocon Biosimilars/Follow-on-Biologics Product Offered
13.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biocon Main Business Overview
13.6.5 Biocon Latest Developments
13.7 Hospira
13.7.1 Hospira Company Information
13.7.2 Hospira Biosimilars/Follow-on-Biologics Product Offered
13.7.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hospira Main Business Overview
13.7.5 Hospira Latest Developments
13.8 Merck Group
13.8.1 Merck Group Company Information
13.8.2 Merck Group Biosimilars/Follow-on-Biologics Product Offered
13.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck Group Main Business Overview
13.8.5 Merck Group Latest Developments
13.9 Biogen idec, Inc.
13.9.1 Biogen idec, Inc. Company Information
13.9.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered
13.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Biogen idec, Inc. Main Business Overview
13.9.5 Biogen idec, Inc. Latest Developments
13.10 Genentech (Roche Group)
13.10.1 Genentech (Roche Group) Company Information
13.10.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered
13.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Genentech (Roche Group) Main Business Overview
13.10.5 Genentech (Roche Group) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Country/Region, 2017, 2022 & 2028
2.2 Biosimilars/Follow-on-Biologics Segment by Type
2.2.1 Human Growth Hormone
2.2.2 Erythropoietin
2.2.3 Monoclonal Antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.2.7 Peptide
2.2.8 Others
2.3 Biosimilars/Follow-on-Biologics Sales by Type
2.3.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
2.3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022)
2.4 Biosimilars/Follow-on-Biologics Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.4.3 Chronic and Autoimmune Diseases
2.4.4 Growth Hormone Deficiencies
2.4.5 Others
2.5 Biosimilars/Follow-on-Biologics Sales by Application
2.5.1 Global Biosimilars/Follow-on-Biologics Sale Market Share by Application (2017-2022)
2.5.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022)
3 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY COMPANY
3.1 Global Biosimilars/Follow-on-Biologics Breakdown Data by Company
3.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Company (2020-2022)
3.1.2 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)
3.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Company (2020-2022)
3.2.1 Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022)
3.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)
3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Company
3.4 Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilars/Follow-on-Biologics Product Location Distribution
3.4.2 Players Biosimilars/Follow-on-Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Biosimilars/Follow-on-Biologics Market Size by Geographic Region (2017-2022)
4.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Geographic Region
4.2 World Historic Biosimilars/Follow-on-Biologics Market Size by Country/Region (2017-2022)
4.2.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Country/Region
4.3 Americas Biosimilars/Follow-on-Biologics Sales Growth
4.4 APAC Biosimilars/Follow-on-Biologics Sales Growth
4.5 Europe Biosimilars/Follow-on-Biologics Sales Growth
4.6 Middle East & Africa Biosimilars/Follow-on-Biologics Sales Growth
5 AMERICAS
5.1 Americas Biosimilars/Follow-on-Biologics Sales by Country
5.1.1 Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
5.1.2 Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
5.2 Americas Biosimilars/Follow-on-Biologics Sales by Type
5.3 Americas Biosimilars/Follow-on-Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars/Follow-on-Biologics Sales by Region
6.1.1 APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022)
6.1.2 APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022)
6.2 APAC Biosimilars/Follow-on-Biologics Sales by Type
6.3 APAC Biosimilars/Follow-on-Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biosimilars/Follow-on-Biologics by Country
7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
7.2 Europe Biosimilars/Follow-on-Biologics Sales by Type
7.3 Europe Biosimilars/Follow-on-Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars/Follow-on-Biologics by Country
8.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
8.2 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type
8.3 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics
10.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
10.4 Industry Chain Structure of Biosimilars/Follow-on-Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilars/Follow-on-Biologics Distributors
11.3 Biosimilars/Follow-on-Biologics Customer
12 WORLD FORECAST REVIEW FOR BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Region
12.1.1 Global Biosimilars/Follow-on-Biologics Forecast by Region (2023-2028)
12.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilars/Follow-on-Biologics Forecast by Type
12.7 Global Biosimilars/Follow-on-Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Biosimilars/Follow-on-Biologics Product Offered
13.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Synthon Pharmaceuticals
13.2.1 Synthon Pharmaceuticals Company Information
13.2.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered
13.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Synthon Pharmaceuticals Main Business Overview
13.2.5 Synthon Pharmaceuticals Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered
13.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 LG Life Sciences
13.4.1 LG Life Sciences Company Information
13.4.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered
13.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 LG Life Sciences Main Business Overview
13.4.5 LG Life Sciences Latest Developments
13.5 Celltrion
13.5.1 Celltrion Company Information
13.5.2 Celltrion Biosimilars/Follow-on-Biologics Product Offered
13.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Celltrion Main Business Overview
13.5.5 Celltrion Latest Developments
13.6 Biocon
13.6.1 Biocon Company Information
13.6.2 Biocon Biosimilars/Follow-on-Biologics Product Offered
13.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biocon Main Business Overview
13.6.5 Biocon Latest Developments
13.7 Hospira
13.7.1 Hospira Company Information
13.7.2 Hospira Biosimilars/Follow-on-Biologics Product Offered
13.7.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hospira Main Business Overview
13.7.5 Hospira Latest Developments
13.8 Merck Group
13.8.1 Merck Group Company Information
13.8.2 Merck Group Biosimilars/Follow-on-Biologics Product Offered
13.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck Group Main Business Overview
13.8.5 Merck Group Latest Developments
13.9 Biogen idec, Inc.
13.9.1 Biogen idec, Inc. Company Information
13.9.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered
13.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Biogen idec, Inc. Main Business Overview
13.9.5 Biogen idec, Inc. Latest Developments
13.10 Genentech (Roche Group)
13.10.1 Genentech (Roche Group) Company Information
13.10.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered
13.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Genentech (Roche Group) Main Business Overview
13.10.5 Genentech (Roche Group) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Human Growth Hormone
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Insulin
Table 7. Major Players of Interferon
Table 8. Major Players of Granulocyte-Colony Stimulating Factor
Table 9. Major Players of Peptide
Table 10. Major Players of Others
Table 11. Global Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 12. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 13. Global Biosimilars/Follow-on-Biologics Revenue by Type (2017-2022) & ($ million)
Table 14. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)
Table 15. Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022) & (USD/Pcs)
Table 16. Global Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 18. Global Biosimilars/Follow-on-Biologics Revenue by Application (2017-2022)
Table 19. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2017-2022)
Table 20. Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022) & (USD/Pcs)
Table 21. Global Biosimilars/Follow-on-Biologics Sales by Company (2020-2022) & (K Pcs)
Table 22. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)
Table 23. Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022) ($ Millions)
Table 24. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)
Table 25. Global Biosimilars/Follow-on-Biologics Sale Price by Company (2020-2022) & (USD/Pcs)
Table 26. Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution and Sales Area
Table 27. Players Biosimilars/Follow-on-Biologics Products Offered
Table 28. Biosimilars/Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Biosimilars/Follow-on-Biologics Sales by Geographic Region (2017-2022) & (K Pcs)
Table 32. Global Biosimilars/Follow-on-Biologics Sales Market Share Geographic Region (2017-2022)
Table 33. Global Biosimilars/Follow-on-Biologics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region (2017-2022)
Table 35. Global Biosimilars/Follow-on-Biologics Sales by Country/Region (2017-2022) & (K Pcs)
Table 36. Global Biosimilars/Follow-on-Biologics Sales Market Share by Country/Region (2017-2022)
Table 37. Global Biosimilars/Follow-on-Biologics Revenue by Country/Region (2017-2022) & ($ millions)
Table 38. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region (2017-2022)
Table 39. Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 40. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
Table 41. Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 42. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
Table 43. Americas Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 44. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 45. Americas Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 46. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 47. APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)
Table 48. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)
Table 49. APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & ($ Millions)
Table 50. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2022)
Table 51. APAC Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 52. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 53. APAC Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 54. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 55. Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 56. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
Table 57. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 58. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
Table 59. Europe Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 61. Europe Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 63. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
Table 65. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 66. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
Table 67. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 69. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 70. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 71. Key Market Drivers & Growth Opportunities of Biosimilars/Follow-on-Biologics
Table 72. Key Market Challenges & Risks of Biosimilars/Follow-on-Biologics
Table 73. Key Industry Trends of Biosimilars/Follow-on-Biologics
Table 74. Biosimilars/Follow-on-Biologics Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Biosimilars/Follow-on-Biologics Distributors List
Table 77. Biosimilars/Follow-on-Biologics Customer List
Table 78. Global Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. Global Biosimilars/Follow-on-Biologics Sales Market Forecast by Region
Table 80. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 82. Americas Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Americas Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. APAC Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)
Table 85. APAC Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 86. Europe Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Europe Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
Table 89. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 90. Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2023-2028) & (K Pcs)
Table 91. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Type (2023-2028)
Table 92. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 93. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Type (2023-2028)
Table 94. Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2023-2028) & (K Pcs)
Table 95. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Application (2023-2028)
Table 96. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 97. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Application (2023-2028)
Table 98. Novartis Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Biosimilars/Follow-on-Biologics Product Offered
Table 100. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Synthon Pharmaceuticals Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered
Table 105. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Synthon Pharmaceuticals Main Business
Table 107. Synthon Pharmaceuticals Latest Developments
Table 108. Teva Pharmaceutical Industries Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered
Table 110. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. Teva Pharmaceutical Industries Main Business
Table 112. Teva Pharmaceutical Industries Latest Developments
Table 113. LG Life Sciences Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered
Table 115. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 116. LG Life Sciences Main Business
Table 117. LG Life Sciences Latest Developments
Table 118. Celltrion Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. Celltrion Biosimilars/Follow-on-Biologics Product Offered
Table 120. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 121. Celltrion Main Business
Table 122. Celltrion Latest Developments
Table 123. Biocon Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 124. Biocon Biosimilars/Follow-on-Biologics Product Offered
Table 125. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 126. Biocon Main Business
Table 127. Biocon Latest Developments
Table 128. Hospira Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 129. Hospira Biosimilars/Follow-on-Biologics Product Offered
Table 130. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 131. Hospira Main Business
Table 132. Hospira Latest Developments
Table 133. Merck Group Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 134. Merck Group Biosimilars/Follow-on-Biologics Product Offered
Table 135. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 136. Merck Group Main Business
Table 137. Merck Group Latest Developments
Table 138. Biogen idec, Inc. Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 139. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered
Table 140. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 141. Biogen idec, Inc. Main Business
Table 142. Biogen idec, Inc. Latest Developments
Table 143. Genentech (Roche Group) Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 144. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered
Table 145. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 146. Genentech (Roche Group) Main Business
Table 147. Genentech (Roche Group) Latest Developments
Table 1. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Human Growth Hormone
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Insulin
Table 7. Major Players of Interferon
Table 8. Major Players of Granulocyte-Colony Stimulating Factor
Table 9. Major Players of Peptide
Table 10. Major Players of Others
Table 11. Global Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 12. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 13. Global Biosimilars/Follow-on-Biologics Revenue by Type (2017-2022) & ($ million)
Table 14. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)
Table 15. Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022) & (USD/Pcs)
Table 16. Global Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 18. Global Biosimilars/Follow-on-Biologics Revenue by Application (2017-2022)
Table 19. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2017-2022)
Table 20. Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022) & (USD/Pcs)
Table 21. Global Biosimilars/Follow-on-Biologics Sales by Company (2020-2022) & (K Pcs)
Table 22. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)
Table 23. Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022) ($ Millions)
Table 24. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)
Table 25. Global Biosimilars/Follow-on-Biologics Sale Price by Company (2020-2022) & (USD/Pcs)
Table 26. Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution and Sales Area
Table 27. Players Biosimilars/Follow-on-Biologics Products Offered
Table 28. Biosimilars/Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Biosimilars/Follow-on-Biologics Sales by Geographic Region (2017-2022) & (K Pcs)
Table 32. Global Biosimilars/Follow-on-Biologics Sales Market Share Geographic Region (2017-2022)
Table 33. Global Biosimilars/Follow-on-Biologics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region (2017-2022)
Table 35. Global Biosimilars/Follow-on-Biologics Sales by Country/Region (2017-2022) & (K Pcs)
Table 36. Global Biosimilars/Follow-on-Biologics Sales Market Share by Country/Region (2017-2022)
Table 37. Global Biosimilars/Follow-on-Biologics Revenue by Country/Region (2017-2022) & ($ millions)
Table 38. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region (2017-2022)
Table 39. Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 40. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
Table 41. Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 42. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
Table 43. Americas Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 44. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 45. Americas Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 46. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 47. APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)
Table 48. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)
Table 49. APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & ($ Millions)
Table 50. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2022)
Table 51. APAC Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 52. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 53. APAC Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 54. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 55. Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 56. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
Table 57. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 58. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
Table 59. Europe Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 61. Europe Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 63. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
Table 65. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 66. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
Table 67. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
Table 69. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
Table 70. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Table 71. Key Market Drivers & Growth Opportunities of Biosimilars/Follow-on-Biologics
Table 72. Key Market Challenges & Risks of Biosimilars/Follow-on-Biologics
Table 73. Key Industry Trends of Biosimilars/Follow-on-Biologics
Table 74. Biosimilars/Follow-on-Biologics Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Biosimilars/Follow-on-Biologics Distributors List
Table 77. Biosimilars/Follow-on-Biologics Customer List
Table 78. Global Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. Global Biosimilars/Follow-on-Biologics Sales Market Forecast by Region
Table 80. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 82. Americas Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Americas Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. APAC Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)
Table 85. APAC Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 86. Europe Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Europe Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
Table 89. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 90. Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2023-2028) & (K Pcs)
Table 91. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Type (2023-2028)
Table 92. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 93. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Type (2023-2028)
Table 94. Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2023-2028) & (K Pcs)
Table 95. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Application (2023-2028)
Table 96. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 97. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Application (2023-2028)
Table 98. Novartis Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Biosimilars/Follow-on-Biologics Product Offered
Table 100. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Synthon Pharmaceuticals Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered
Table 105. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 106. Synthon Pharmaceuticals Main Business
Table 107. Synthon Pharmaceuticals Latest Developments
Table 108. Teva Pharmaceutical Industries Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered
Table 110. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 111. Teva Pharmaceutical Industries Main Business
Table 112. Teva Pharmaceutical Industries Latest Developments
Table 113. LG Life Sciences Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered
Table 115. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 116. LG Life Sciences Main Business
Table 117. LG Life Sciences Latest Developments
Table 118. Celltrion Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. Celltrion Biosimilars/Follow-on-Biologics Product Offered
Table 120. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 121. Celltrion Main Business
Table 122. Celltrion Latest Developments
Table 123. Biocon Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 124. Biocon Biosimilars/Follow-on-Biologics Product Offered
Table 125. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 126. Biocon Main Business
Table 127. Biocon Latest Developments
Table 128. Hospira Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 129. Hospira Biosimilars/Follow-on-Biologics Product Offered
Table 130. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 131. Hospira Main Business
Table 132. Hospira Latest Developments
Table 133. Merck Group Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 134. Merck Group Biosimilars/Follow-on-Biologics Product Offered
Table 135. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 136. Merck Group Main Business
Table 137. Merck Group Latest Developments
Table 138. Biogen idec, Inc. Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 139. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered
Table 140. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 141. Biogen idec, Inc. Main Business
Table 142. Biogen idec, Inc. Latest Developments
Table 143. Genentech (Roche Group) Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
Table 144. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered
Table 145. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 146. Genentech (Roche Group) Main Business
Table 147. Genentech (Roche Group) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biosimilars/Follow-on-Biologics
Figure 2. Biosimilars/Follow-on-Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilars/Follow-on-Biologics Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Biosimilars/Follow-on-Biologics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biosimilars/Follow-on-Biologics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Human Growth Hormone
Figure 10. Product Picture of Erythropoietin
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Interferon
Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 15. Product Picture of Peptide
Figure 16. Product Picture of Others
Figure 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2021
Figure 18. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)
Figure 19. Biosimilars/Follow-on-Biologics Consumed in Blood Disorders
Figure 20. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2017-2022) & (K Pcs)
Figure 21. Biosimilars/Follow-on-Biologics Consumed in Oncology Diseases
Figure 22. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2017-2022) & (K Pcs)
Figure 23. Biosimilars/Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases
Figure 24. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2017-2022) & (K Pcs)
Figure 25. Biosimilars/Follow-on-Biologics Consumed in Growth Hormone Deficiencies
Figure 26. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2017-2022) & (K Pcs)
Figure 27. Biosimilars/Follow-on-Biologics Consumed in Others
Figure 28. Global Biosimilars/Follow-on-Biologics Market: Others (2017-2022) & (K Pcs)
Figure 29. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Figure 30. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2021
Figure 31. Biosimilars/Follow-on-Biologics Revenue Market by Company in 2021 ($ Million)
Figure 32. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2021
Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region in 2021
Figure 35. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)
Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region in 2021
Figure 37. Americas Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 38. Americas Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 39. APAC Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 40. APAC Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 41. Europe Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 42. Europe Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 44. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 45. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
Figure 46. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
Figure 47. United States Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2021
Figure 52. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2021
Figure 53. China Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 57. India Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
Figure 60. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
Figure 61. Germany Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 62. France Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
Figure 67. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
Figure 68. Egypt Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2021
Figure 74. Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
Figure 75. Industry Chain Structure of Biosimilars/Follow-on-Biologics
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 1. Picture of Biosimilars/Follow-on-Biologics
Figure 2. Biosimilars/Follow-on-Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilars/Follow-on-Biologics Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Biosimilars/Follow-on-Biologics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biosimilars/Follow-on-Biologics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Human Growth Hormone
Figure 10. Product Picture of Erythropoietin
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Interferon
Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor
Figure 15. Product Picture of Peptide
Figure 16. Product Picture of Others
Figure 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2021
Figure 18. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)
Figure 19. Biosimilars/Follow-on-Biologics Consumed in Blood Disorders
Figure 20. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2017-2022) & (K Pcs)
Figure 21. Biosimilars/Follow-on-Biologics Consumed in Oncology Diseases
Figure 22. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2017-2022) & (K Pcs)
Figure 23. Biosimilars/Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases
Figure 24. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2017-2022) & (K Pcs)
Figure 25. Biosimilars/Follow-on-Biologics Consumed in Growth Hormone Deficiencies
Figure 26. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2017-2022) & (K Pcs)
Figure 27. Biosimilars/Follow-on-Biologics Consumed in Others
Figure 28. Global Biosimilars/Follow-on-Biologics Market: Others (2017-2022) & (K Pcs)
Figure 29. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
Figure 30. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2021
Figure 31. Biosimilars/Follow-on-Biologics Revenue Market by Company in 2021 ($ Million)
Figure 32. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2021
Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Geographic Region (2017-2022)
Figure 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region in 2021
Figure 35. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)
Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region in 2021
Figure 37. Americas Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 38. Americas Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 39. APAC Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 40. APAC Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 41. Europe Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 42. Europe Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
Figure 44. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
Figure 45. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
Figure 46. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
Figure 47. United States Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 48. Canada Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Mexico Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Brazil Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 51. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2021
Figure 52. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2021
Figure 53. China Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Japan Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 55. South Korea Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 57. India Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 58. Australia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 59. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
Figure 60. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
Figure 61. Germany Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 62. France Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 63. UK Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 64. Italy Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 65. Russia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 66. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
Figure 67. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
Figure 68. Egypt Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 69. South Africa Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 70. Israel Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 71. Turkey Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 72. GCC Country Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2021
Figure 74. Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
Figure 75. Industry Chain Structure of Biosimilars/Follow-on-Biologics
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
